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in European Wild 
Boars of All Ages
To the Editor: African swine 
fever (ASF) is a serious disease that is 
currently affecting domestic pigs and 
wild boars in the Russian Federation. 
The disease is caused by African 
swine fever virus (ASFV; family 
Asfarviridae), and its continuing 
spread imposes a growing risk for 
introduction to disease-free areas 
with a high density of pigs and/or 
wild boars. We recently reported on 
the experimental characterization of 
ASFV Caucasus isolates in European 
wild boar piglets and juveniles (1), 
age classes that were deemed to be 
the most susceptible to ASFV. The 
extreme virulence of the virus strain 
led to an almost peracute disease and 
100% mortality. On the basis of these 
data, a scenario of endemicity driven 
by chronically diseased animals 
or ASFV carriers seems unlikely. 
Nevertheless, ASF continues to occur 
in wild boars.
The clinical course of some 
infectious diseases is age dependent; 
thus, we supplemented our previous 
study (1) with a limited study among 
adult wild boars to help clarify their 
role in the epidemiology of ASFV. To 
achieve this goal, we orally inoculated 
1 boar (10 years of age), 2 sows (4 
and 5 years, respectively), and 1 boar 
piglet with a 3 × 106 50% tissue culture 
infectious dose of the ASFV Caucasus 
isolate.
Severe, unspecifi c clinical signs 
(fever, depression, anorexia, dyspnea, 
ataxia) developed in all animals. 
Infection was confi rmed by PCR of 
blood samples and fecal and oral 
swab samples obtained 6 days after 
inoculation. All animals died or were 
euthanized in a moribund state 8–9 
days after inoculation, confi rming that 
ASFV causes severe, acute disease 
and is fatal for 100% of infected adult 
European wild boars. No antibodies 
were detected in serum samples 
throughout the experiment. 
The available data show no 
indication of chronic ASF disease or 
ASFV carrier states among adult wild 
boars, conditions that could potentially 
contribute to long-term persistence 
of disease in an affected region. In 
terms of risk assessment, the most 
likely routes for the introduction of 
ASFV into wild boar populations are 
spillover from domestic pigs, exposure 
to ASFV-contaminated carcasses 
under climate conditions favoring the 
persistence of infectious virus, contact 
with fomites, and consumption of 
ASFV-contaminated animal feed.
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